This present study was planned to obtain an up-to-date picture of Hepatitis C virus (HCV) infection and its genotypes distribution in Peshawar, Khyber Pakhtunkhwa, Pakistan, as well as of the relationship between HCV genotypes and demographic and clinical parameters, and the risk factors in patients with an HCV subtype. Samples (blood) from 1978 individuals were collected and were tested using a strip-based method called the immunochromatographic test (ICT) for the existence of antibodies against HCV. It was observed that 158 of the 1978 individuals (7.9%) harbored antibodies in their blood against HCV, among which the female percentage (53.2%) was higher than that of the male (46.8%). Among the different age groups, the highest number of incidences of HCV antibodies was found in the age group of 31e40 years (26.6%). ICT positive samples were further screened by polymerase chain reaction (PCR) to determine the existence of active HCV-RNA, and it was found that 6.21% (123) of the total population (1978) tested, was positive, among which the female rate (56.91%) was observed to be higher than that of the male (43.09%). The highest incidence recorded was in the age group of 41e50 years (33.3%). HCV RNA positive individuals were genotyped: genotype 3a (45.5%) was dominant among the other detected genotypes, followed by 1a (11.4%), 3b (4.9%), and 2a (4.1%). It was concluded that the highest prevalence of HCV was found in females, and that the dominant genotype of the screened individuals was 3a genotype.
Introduction
Hepatitis C is a chronic liver disease mainly caused by a diminutive (50 nm in size) enveloped, positive-sense, single-stranded RNA (ssRNA) virus called Hepatitis C virus (HCV) . HCV is a member of the genus hepacivirus. It was first identified as a new viral agent causing non-A, non-B hepatitis (Chen and Morgan 2006; Choo et al. 1989 ). It is a major cause of liver dysfunction leading to liver injury, cirrhosis and hepatocellular carcinoma, and is a prominent health problem all over the world, especially in developing countries (Wedemeyer et al. 2014) , such as Egypt and Pakistan (Averhoff et al. 2012) . The principal route of transmission of HCV to the host mainly occurs through blood transfusion, un-sterilized surgical instruments, dental surgical instruments, the use of illegal drugs, the sharing of daily use things of an infected person, and acupuncture, while sexual transmission and interfamilial transmission have been also reported (Qureshi et al. 2013) . Although symptoms may be not severe for decades, approximately 20% of infected patients may suffer from lethal liver injury and liver cancer (Imran et al. 2013) . Recently, a report on HCV infection in Pakistan was published in 2007e2008 by the Pakistan Medical Research Council. A total of about 47,000 individuals from the all provinces of Pakistan were screened, and the anti-HCV was found to be present in 4.8% of the population (Dhingra et al. 2014) . In view of the fact that the HCV genome is highly heterogenetic in nature, to date it has been grouped into at least six major genotypes (genotypes 1e6), which can be further classified into various small sub-groups world-wide (Gower et al. 2014) . Of note, the classification of the HCV genotype into groups and subgroups plays a key role in the study of geographical and demographic differences, as well as in molecular epidemiology, vaccine development, therapeutic decision-making, and the study of chronic HCV infection. Hence, it provides important clinical information for health improvement planning and policy. The prevalence of HCV is slightly higher than in developed countries because of the limited availability of resources (Gul et al. 2016) . Although there is a need among the large populations of the developing world to study the relationship of HCV by genotype with age, gender, route of entry and the duration of infection, there is currently a lack of relevant data available. The aim of this present study was therefore to obtain an up-to-date picture of the distribution of HCV infection and its genotypes in Peshawar city, Khyber Pakhtunkhwa, Pakistan, as well as to analyze the relationship between HCV genotypes and demographic and clinical parameters, and to look at the risk factors present in patients with an HCV subtype.
The hope is that this present study will also help to draw the attention of local and foreign organizations to this important issue. Peshawar city was decided on as a good site to conduct the research because of the very low literacy rate in almost all of its districts, the limited availability of health facilities, and the frequency of natural disasters such as floods. The polymerase chain reaction (PCR) method holds an advantage over non-PCR immunoassays such as enzyme-linked immunosorbent assay (ELISA), recombinant immunoblot assay (RIBA), enzyme linked immunosorbent assay (EIA), immunochromatographic test (ICT), and so on, being a quick and reliable tool to diagnose, genotype and quantify active HCV RNA in the blood. However, to date, there is no PCR-based prevalence studies with large sample numbers available for the population of Pakistan.
Materials and Methods

Sampling
This study was conducted in the Alfalah PCR Laboratory and Research Center, Dabgari Garden capital province Peshawar, Khyber Pakhtunkhwa, Pakistan from February 2013 to January 2015, in which blood samples of 1978 individuals comprising 809 males and 1169 females were taken through sera and extracted. All necessary information were gained through proper questionnaires, informed consent and ethical approvals were taken from each infected patient as directed by expert physician and owner of the hospital, and kept confidential. All the individuals were categorized into age groups 10e20, 21e30, 31e40, 41e50 and over 50 years, respectively.
Initial screening
Initially, the sera were screened for the presence of anti-HCV antibodies using a strip-based method called an ICT. For this purpose, a commercially available kit (ACON ® , ACON Laboratories Inc., San Diego, CA, USA) was used according to the protocol recommended by the manufacturer. The positive samples were further processed for molecular detection and genotyping.
PCR confirmation of HCV
From the samples that had tested positive for anti-HCV antibodies, HCV RNA was extracted using a TRIzol reagent (Invitrogen, Carlsbad, USA) following the protocol recommended by the company. The complementary DNA (cDNA) was synthesized using genespecific reverse primers by reverse transcription, using Moloney murine leukemia virus reverse transcriptase at 37 C for 50 minutes. The viral RNA was confirmed through PCR using primers (F): 5 0 -CCCTGTGAGGAACTACTGTCTTCACGC-3 0 , and (R): 5 0 -ACTCGCAAGCACCCTATCAGGCAGTAC-3 0 , whereas the primers used for internal core region amplification were:
Forward: 5 0 -GAAAGCGTCTAGCCATGGCG-3 0 and Reverse: 5 0 -CACAAGGCCTTTCGCGACC-3 0 .
PCR-based identification of HCV strains
RNA from each sample was isolated by following the Ohno et al. (1997) protocol. Reverse transcription PCR was performed for viral cDNA generation using core gene-specific reverse primers, and multiplex-PCR was performed for genotypes identification. Two reaction mixtures, containing two sets of primers each, were processed in parallel in the nested PCR (Table 1 ). The PCR-thermal cycler was set to 94 C for 5 minutes for pre-denaturation, followed by denaturation at 94 C for 30 seconds (30 cycles). Primer annealing was carried out at 64 C for 30 seconds; this was followed by an extension at 72 C for 30 seconds, and a final temperature of 4 C for 10 minutes. The same conditions were applied for the nested PCR; however, primer annealing was carried out at 53 C.
Results
Initial screening
A total of 1978 individuals consisting of 809 males and 1169 females were initially screened using ICT for the presence of antibodies against HCV. The results showed that 158 of the 1978 individuals (7.9%) were positive. Among the positive individuals, 74 (46.8%) were males and 84 (53.2%) were females (Figure 1 ).
PCR-based confirmation of active HCV
The detection of antibodies against HCV is not a reliable test for HCV. Therefore, all anti-HCV carrying samples were confirmed for the presence of HCV RNA using PCR (Figure 2 ). It was observed that 123 individuals (77.8%) tested positive for the presence of HCV RNA. More incidences were observed in females (70; 56.91%) as compared with males (53; 43.09%) (Figure 1 ).
Among the different age groups, the highest incidence of anti-HCV antibodies (42; 26.6%) was observed in the following age groups: 31e40 years, followed by the 21e30 years (35; 22.2%), 51 G2b  GGCCCCAATTAGGACGAGAC  337  G3b  CGCTCGGAAGTCTTACGTAC  176  Mix2 primer  S7  AGACCGTGCACCATGAGCAC  G1a  GGATAGGCTGACGTCTACCT  208  G3a  GCCCAGGACCGGCCTTCGCT  232  G4  CCCGGGAACTTAACGTCCAT  99  G5a  GAACCTCGGGGGGAGAGCAA  320  G6a GGTCATTGGGGCCCCAATGT 346
For the naming of primers, S ¼ sense; A or G ¼ antisense and C ¼ core region; the notations 1ae6a are in accordance with the HCV genotype nomenclature proposed by Simmonds et al. (1994) . Numbering is from the authentic start codon of the open reading frame. 2s, second-round PCR for sequencing; 2g, second-round PCR for genotyping. Pairs of nucleotides inside parentheses denote degenerate nucleotides sequence.
years and above (33; 20.9%), 41e50 years (30; 19%) and 10e20 years (18; 11.4%) (Figure 3) . Similarly, the highest incidence of the presence of HCV RNA was observed in the following age groups: 41e50 years (41; 33.3%), followed by 31e40 years (27; 22.0%), 51 years and above (24; 19.5%), 21e30 years (20; 16.3%) and 10e20 years (11; 8.9%) (Figure 3 ).
Distribution of HCV genotypes among different age groups
The HCV RNA positive samples (123) were genotyped. Among the samples tested, genotype 3a was found to be the most dominant genotype, being detected in 56 of 123 individuals (45.5%) among all the age groups. The second most dominant viral genotype was 1a, which was detected in 14 individuals (11.4%), followed by 3b and 2a which were detected in 6 (4.9%) and 5 (4.1%) individuals, respectively. A total of 22 samples (17.9%) were found with untypeable genotypes, as no genotype-specific PCR fragments band was observed, whereas the infection of two (mixed) different genotypes was observed in 20 individuals (16.3%) (Figure 4 ).
Discussion
Viral hepatitis is alarmingly high among the general population of Pakistan; ten million people or 6% of the total population of Pakistan is infected with HCV (Raja and Janjua 2008) . In this study, a random sample was taken from the mixed population of Peshawar city, Pakistan, including the majority Pashtun, other smaller ethnic groups such as the Hindkowans, Dards, Chitralis and Gujjars, and Afghan refugees. The molecular epidemiology of HCV varies by region and in different groups of the same population (Idrees et al. 2008, Wild and Hall 2000) . In our study, 6.21% prevalence of HCV was observed, which is comparatively higher than that of Islamabad (5.31%) (Idrees et al. 2008) , Rawalpindi (2.45%) (Masood et al. 2007) , Bunir (5%) (Muhammad and Jan 2005) , Multan (4.06%) (Idrees et al. 2008) , Karachi (4%e6%) (Khan et al. 2011) , and lower than that of Faisalabad (20.89%) (Ahmad et al. 2007) , Mardan (9%) (Ali et al. 2010) and Northern Areas (25.7%) (Tariq et al. 1999) . This could be due to various factors including the lack of quality health care, poor literacy rate, low average socio-economic status, general lack of awareness, lack of availability of suitable screening facilities, and differences in population samples selected for the study (Shah et al. 1997) . When comparing the different age groups, we found that the highest prevalence of HCV infection occurred among adult men. Age has been argued to be a major factor in HCV studies, with infection more predominant in older persons (Cozzolongo et al. 2009 , Mengal et al. 2012 . Our study clearly indicates the dominance of genotypes 3a (45.5%) and 1a (11.4%) among the tested population. These results validate the findings of Ahmad et al. (2010) , who reported that 59.9% and 16.5% of individuals were infected with 3a and 1a genotypes, respectively, both these being higher percentages than the other genotypes detected. Many other studies have also reported that genotype 3a occurs most frequently in Pakistan (Afridi et al. 2014 , Ahmad et al. 2010 . Genotype 4a was not detected in our study; this genotype seems to be very rare in Pakistan. However, Ahmad et al. (2010) isolated genotype 4a in a study of prevalence in Lahore, Pakistan. Other studies reveal that genotype 4a is prevalent in the Middle East (Abdulkarim et al. 1998 , Gower et al. 2014 . Genotypes 5a and 6a were also not isolated in our study. Acquaintance about the occurrence of different HCV genotypes in different regions of Pakistan is considered to be an important clinical parameter for molecular epidemiology, vaccine development, therapeutic implications and chronic HCV infection (Ahmad et al. 2010 , Ali et al. 2010 . HCV is reported to exhibit elevated levels of genetic variation. On the basis of nucleotide sequences recuperated from HCV infected persons, HCV is categorized into six genotypes and several subtypes (Smith et al. 2014) . These genotypes showed 30%e35% nucleotide differences in their genomes. However, these differences are not evenly spread throughout the genome, as a very large variability is present within the viral glycoproteins (Simmonds 2004) . HCV genotypes show a discrepancy in distribution. Genotypes 1e3 are very widely distributed, whereas genotype 4 is more prominent in Africa and the Middle East, genotype 5 is prominent in South Africa, genotype 6 in South East Asia and genotype 7 in Central Africa (Gower et al. 2014 , Simmonds 2004 ).
In our study, an unknown HCV genotype was detected in 27 of 123 individuals (17.9%). Most HCV studies in Pakistan reveal the isolation and detection of an unknown/undetermined HCV genotype (Ahmad et al. 2010 , Ali et al. 2010 , Rauf et al. 2011 . In future, a significant challenge for researchers and experts is the identification of this/these unknown genotype(s), and the exploration of its/ their possible role in the development of Hepatitis C. This will help to ease clinical management, the process of diagnosis, vaccine development and other prevention measures.
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